Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	137.64	298.4	171.45	130.25	89.52
Short-Term Investments	0	0	19.82	10.04	5.01
Cash & Cash Equivalents	137.64	298.4	191.28	140.29	94.53
Cash Growth	-53.87%	56.00%	36.35%	48.41%	76.72%
Receivables	53.51	10.44	6.62	5.99	10.54
Inventory	15.64	6.81	7.87	4.65	1.96
Other Current Assets	12.54	5.17	4.34	8.32	4.34
Total Current Assets	219.33	320.81	210.11	159.24	111.36
Property, Plant & Equipment	3.7	3.62	3.98	0.13	1
Long-Term Investments	16.49	0	0	0	0
Goodwill and Intangibles	194.05	32.47	0	0	0
Other Long-Term Assets	36.54	18.74	23.71	32.98	0.01
Total Long-Term Assets	250.79	54.82	27.68	33.11	1.01
Total Assets	470.11	375.63	237.79	192.35	112.38
Accounts Payable	14.8	3.98	2.77	4.26	4.12
Other Current Liabilities	61.27	53.61	24.3	18.5	19.98
Total Current Liabilities	76.06	57.59	27.06	22.76	24.1
Long-Term Debt	3.19	3.56	3.89	0	0.65
Other Long-Term Liabilities	2.98	14.06	0	0	0
Total Long-Term Liabilities	6.17	17.62	3.89	0	0.65
Total Liabilities	82.23	75.21	30.96	22.76	24.75
Total Debt	3.19	3.56	3.89	0	0.65
Debt Growth	-10.37%	-8.65%	-	-	-
Retained Earnings	121.27	49.86	-26.31	-53.71	-128.69
Comprehensive Income	0.01	0.02	-0.15	0.03	0.01
Shareholders' Equity	387.88	300.42	206.83	169.6	87.63
Net Cash / Debt	134.45	294.84	187.38	140.29	93.88
Net Cash / Debt Growth	-54.40%	57.35%	33.57%	49.43%	75.51%
Net Cash Per Share	1.18	2.65	1.74	1.32	0.89
Working Capital	143.27	263.22	183.04	136.49	87.26
Book Value Per Share	3.65	2.91	2.00	1.64	0.85

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).